BAC Stock: Buy or Sell? Price Target & Forecast

Analyses / BAC

BAC Bank of America Corp As of Sep 15, 2026

$59.47

Large-cap bank down 5% intraday; dividend yield 3.2%, valuation at decade lows, insider selling pressure.

Setup: Value / Income Confidence: 62 Horizon: 3-6 months Risk: Medium Category: Large-Cap Bank

🔒 Trade Plan — entry · target · stop

Entry Zone

$•••–•••

Target

$•••

Stop Loss

$•••

Risk / Reward

•.• : 1

Unlock the exact levels — free →

A free account reveals BAC's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

P/E 12.9x and forward P/E 14.2x sit well below S&P 500 average; 3.2% dividend yield attractive in rising-rate environment. Net margin 29% signals operational efficiency. 5-year EPS growth 14.3% despite macro headwinds. Price-to-book 1.32x reflects reasonable premium for systemically important lender.

▼ Bear Case

Down 5% today on investment banking fee shortfall signal. Insider selling significantly outpaces buying (262 sells vs 177 buys). Price-to-FCF 34.3x elevated for bank, suggesting cash conversion concerns. Revenue growth flat (0.6% YoY) and slowing — long-term growth only 4.7% annually. Rising rates may compress net interest margins.

Valuation

Undervalued — score 72/100

P/E 12.9x and forward P/E 14.2x trade below S&P 500 ~18–19x; P/B 1.32x reasonable for large cap bank. Yield 3.2% attractive. However, revenue growth flat and 5-year trajectory weak (4.7%); price-to-FCF 34.3x suggests market skepticism on cash generation.

Technical Levels

Support · $57.50 (Recent intraday low; near-term support) · $55.00 (Stop-loss level; psychological / technical floor) · $46.12 (52-week low)

Resistance · $62.69 (Prior close; near-term resistance) · $65.23 (52-week high) · $68.00 (Illustrative 1.6x P/B level)

RSI: Not provided

Financial Health

Score 62/100. Profitability metrics solid (net margin 29%, operating margin 32.6%); 5-year EPS growth 14.3% robust. However, revenue growth nearly flat YoY (0.6%) and 5-year CAGR weak (4.7%), signaling organic growth challenges. Critical balance sheet metrics (debt-to-equity, liquidity ratios, interest coverage) unavailable; leverage and stability cannot be fully assessed.

Catalysts

Q3 2024 earnings report	Mid–late October (typical)	High. Guidance on investment banking recovery, loan loss provisions, net interest margin trend, and dividend coverage critical. Beat/miss will set tone for valuation re-rating.
Federal Reserve rate decision & guidance	Ongoing; next major decision Sept 2024	High. Fed cuts may ease NIM pressure; prolonged high rates could compress profitability. Market pricing shifts immediately on Fed signals.
M&A / sector consolidation news	Unpredictable	Medium-High. Large bank M&A could drive BAC shares if buyer or synergy play; conversely, regional bank stress could raise regulatory scrutiny on BAC.
Economic data: employment, inflation, GDP	Monthly releases	Medium. Weakening data supports Fed cut narrative, easing margin pressure. Recession fears spike loan loss provisions and credit stress.
Insider transaction activity	Ongoing	Medium. Insider selling currently outpaces buying (262:177); reversal to buying could signal management confidence.

Risk Flags

Intraday 5% drop tied to investment banking fee miss; sentiment fragile near-term.

Insider selling ratio (262:177) suggests management caution despite valuation appeal.

Price-to-FCF 34.3x high for financials; cash generation may not support dividend over cycle.

Provider data missing: ROE, ROA, ROIC, debt-to-equity, current/quick ratios, interest coverage — critical metrics for bank health assessment.

EV/EBITDA, PEG, fundamental balance sheet & cash flow detail unavailable; analysis limited to available metrics.

See BAC's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock BAC free →

More Analyses

NVDA

AAPL

TSLA

MSFT

AMZN

GOOGL

BAC FAQ

Is BAC a buy right now?

Bank of America Corp's current read is a Value / Income setup with 62 confidence over a 3-6 months horizon. Valuation: Undervalued. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is BAC overvalued?

Undervalued (valuation score 72/100). P/E 12.9x and forward P/E 14.2x trade below S&P 500 ~18–19x; P/B 1.32x reasonable for large cap bank. Yield 3.2% attractive. However, revenue growth flat and 5-year trajectory weak (4.7%); price-to-FCF 34.3x suggests market skepticism on cash generation.

What are the risks of buying BAC?